Akbar Indo Makmur Stimec Tbk vs Merck Tbk. — how do they compare? Akbar Indo Makmur Stimec Tbk trades at Rp386 (market cap 84.48B, 144.8K 24h volume), while Merck Tbk. trades at Rp3,890 (market cap 1.75T, 29.1K 24h volume). The key difference: Merck Tbk. is far larger — about 20.7× Akbar Indo Makmur Stimec Tbk's market cap, and Akbar Indo Makmur Stimec Tbk is more actively traded (144.8K versus 29.1K). Which is the better fit depends on your goals.
| AIMS | MERK | |
|---|---|---|
Market Cap | 84.48B | 1.75T |
Volume | 144.8K | 29.1K |
Lot | 1.45K | 291 |
Turnover | 56.56M | 113.37M |
Average Price | 390.62 | 3,895.98 |
Value | 56.56M | 113.37M |
Indicative Equilibrium Price | 386 | 3,890 |
Indicative Equilibrium Volume | 112 | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Akbar Indo Makmur Tbk was established on May 7th 1997. On November 17th, 2000, PT. Stimec merged by PT. Akbar Indo Makmur and changed to be PT. Akbar Indo Makmur Stimec.
Read more on AIMS →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →